Akihito Tanaka

14PUBLICATIONS
24CO-AUTHORS
Major global burdens of diseaseColloid and surface chemistryRehabilitationMolecular targetsNaturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 18, 2026
Evaluation of Puromycin-Induced Podocyte Injury and Protective Effects of Voclosporin Using Induced Pluripotent Stem Cells from a Patient with Nephrotic Syndrome Harboring an INF2 Variant.

|Jun 04, 2026
Effective Low-Density Lipoprotein Apheresis for Relapse Minimal Change Nephrotic Syndrome in an Adult Patient With Acute Kidney Injury and Pneumococcal Infection: A Case Report.

|Nov 20, 2025
Frequency of Home Therapy Among Patients Who Underwent Kidney Transplantation Followed by Maintenance Dialysis.

Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda

|Apr 03, 2025
Ameliorative Effect of an Anti-MicroRNA-21 Oligonucleotide on Animal and Human Models of Cystic Kidney Disease.

Yuhei Noda, Noritoshi Kato, Fuminori Sato

|Mar 18, 2025
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.

Shinobu Shimizu, Akihito Tanaka, Nao Matsuyama

|Aug 26, 2024
Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy.

Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda

Pageof 3

Frequent Collaborators

3 joint publications

Daijo Inaguma

2 joint publications

Eri Koshi-Ito

2 joint publications

Kumiko Fujieda

2 joint publications

Shoji Saito